-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GtJFnOZis9jcvnp3E+dSbH2WYc5Ouf2RgQ/YJD4OBHHJuC7CEOcnVVlX3fVOGESz vjjK/LvKCa8QFa3LVoAIrw== 0000950123-98-000610.txt : 19980129 0000950123-98-000610.hdr.sgml : 19980129 ACCESSION NUMBER: 0000950123-98-000610 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980128 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COLLABORATIVE CLINICAL RESEARCH INC CENTRAL INDEX KEY: 0000886530 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 341685364 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-48311 FILM NUMBER: 98515056 BUSINESS ADDRESS: STREET 1: 20600 CHAGRIN BLVD STREET 2: STE 1050 CITY: CLEVELAND STATE: OH ZIP: 44122 BUSINESS PHONE: 2164919930 MAIL ADDRESS: STREET 1: 20600 CHAGRIN BLVD STREET 2: STE 1050 CITY: CLEVELAND STATE: OH ZIP: 44122 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DELTEC ASSET MANAGEMENT CORP/ CENTRAL INDEX KEY: 0000937906 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 135133790 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 535 MADISON AVENUE 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2122301400 MAIL ADDRESS: STREET 1: 535 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 SC 13G/A 1 COLLABORATIVE CLINICAL RESEARCH 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities and Exchange Act of 1934 (Amendment No. 2)* COLLABORATIVE CLINICAL RESEARCH ------------------------------------------------------------------------------ (Name of Issuer) COMMON STOCK ------------------------------------------------------------------------------ (Title of Class of Securities) 194190 10 4 ------------------------------------------------------------------------------ (CUSIP Number) Check the following box if a fee is being paid with this statement ( ). (Continued on following page (s) ) (Page 1 of 6 Pages) 2 CUSIP NO. 194190 10 4 13G PAGE 2 OF 6 PAGES 1 NAME OF REPORTING PERSON - Deltec Asset Management Corporation S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON I.R.S. No. 13-5133790 2 CHECK APPROPRIATE BOX IF A MEMBER OF GROUP * (A) ___ (B) (X) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION State of New York 5. SOLE VOTING POWER NOT APPLICABLE 6. SHARED VOTING POWER NOT APPLICABLE 7. SOLE DISPOSITIVE POWER NOT APPLICABLE 8. SHARED DISPOSITIVE POWER NOT APPLICABLE 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON NOT APPLICABLE 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES * 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 - NOT APPLICABLE 12. TYPE OF REPORTING PERSON* BD, IA, CO Page 2 of 6 3 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 10549 ---------------------------------------------------------------------- SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 ---------------------------------------------------------------------- Item 1. (a) Name of Issuer: Collaborative Clinical Research (b) Address of Issuer's Principal Executive Offices: 20600 Chagrin Blvd Suite 1050 Cleveland, OH 44122 Item 2. (a) Name of Person Filing: Deltec Asset Management Corporation (b) Address of Principal Business Office: 535 Madison Avenue New York, NY 10022 Page 3 of 6 4 Item 2. (c) Citizenship: State of New York (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 194190 10 4 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) Broker Dealer registered under Section 15 of the Act (x) (b) Bank as defined in Section 3(a)(6) of the Act, (c) Insurance Company as defined in Section 3(a)(19) of the Act, (d) Investment Company registered under Section 8 of the Investment Company Act (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940, (x) (f) Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F), (g) Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G) (h) Group, in accordance with Rule 13d-1(b)(1)(ii)(H) Item 4. Ownership (a). Amount Beneficially Owned: NOT APPLICABLE - SEE ITEM 5 (b) Percent of Class: NOT APPLICABLE (c) Number of shares to which such person has: (i) sole power to vote or to direct to vote: NOT APPLICABLE (ii) shared power to vote or to direct the vote: NOT APPLICABLE (iii) sole power to dispose or to direct the disposition of: NOT APPLICABLE (iv) shared power to dispose or to direct the disposition of: NOT APPLICABLE Page 4 of 6 Pages 5 Item 5. Ownership of Five Percent or Less of a Class: This Amendment No. 2 to the Reporting Person's Statement on Schedule 13G is being filed to report that, as of December 31, 1997, and as of the date hereof, the Reporting Person owned no shares of Collaborative Clinical Research, Inc. Item 6. Ownership of More Than Five Percent on Behalf of Another Person: NOT APPLICABLE. Item 7: Identification and Classification of Subsidiaries which Acquired the Security Being Reported on by the Parent Holding Company: NOT APPLICABLE. Item 8. Identification and Classification of Members of the Group: NOT APPLICABLE. Page 5 of 6 6 Item 9. Notice of Dissolution of Group: NOT APPLICABLE. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement concerning the undersigned is true, complete and correct. Dated: January 26, 1998 DELTEC ASSET MANAGEMENT CORPORATION By /s/ Stephen Zuppello --------------------------------------- Stephen Zuppello Chief Operating Officer Page 6 of 6 -----END PRIVACY-ENHANCED MESSAGE-----